{
  "docId": "019de072-118b-7459-8ccb-22724833fcd4",
  "docSlug": "04de07fbea9eadeda44cc99f91069101",
  "documentTitle": "AbCellera | Results Presentation Deck | 21 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 21,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "revenue_buildup",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The chart uses a timeline axis (3m to 24m) and maps revenue streams to specific development stages.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/8",
  "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4",
  "deckJsonHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4.json",
  "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.266,
        "x": 0.618,
        "y": 0.277
      },
      "kind": "callout",
      "text": "royalties in aggregate of $526 million (to Dec 31, 2021), over 95% of total program revenue",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e26bbf0-8e61-4b18-8eac-71fc9523f25d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.105,
        "x": 0.23,
        "y": 0.648
      },
      "kind": "callout",
      "text": "research fees <$5 million",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "506a8231-a7c0-4e80-8654-b1cbbdbdeeb2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.085,
        "w": 0.105,
        "x": 0.368,
        "y": 0.382
      },
      "kind": "callout",
      "text": "approval & commercial milestones $14 million",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6477c830-ea10-4ef2-b0a3-684f57e10698",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.105,
        "x": 0.33,
        "y": 0.558
      },
      "kind": "callout",
      "text": "clinical milestones $8 million",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b683df5a-0573-497c-8f9a-b86510355b51",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.65,
        "x": 0.23,
        "y": 0.35
      },
      "kind": "chart",
      "text": null,
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb075a16-3efb-4bbc-b8b9-25c41604f288",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.435,
        "x": 0.103,
        "y": 0.185
      },
      "kind": "title",
      "text": "Similar revenue structure to typical program realized on a compressed timeline.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b357aeca-a72f-4ed0-8615-0f12861e7b5a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.435,
        "x": 0.103,
        "y": 0.068
      },
      "kind": "title",
      "text": "COVID-19 ANTIBODY PROGRAM.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53c3a53b-495a-4b64-a5ba-0af2ac041201",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "d783f1b6-125a-428a-9d63-8a288995af02",
      "evidence": "The slide uses a chronological axis to show revenue progression over 24 months.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 13,
      "from": 7,
      "beatId": "bf52f0f4-f71c-45d7-83ba-6d61d5147353",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The presentation showcases the company's strong growth in royalty rates, flexible deal structures, and advancements in GPCRs, ion channels & bispecific antibodies.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 13,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "c116a9b9-66b9-474f-8411-60fed0150046",
      "evidence": "The presentation explains the company's technology and its applications.",
      "position": 0,
      "objective": "Why AbCellera's technology is important for antibody discovery",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    },
    {
      "to": 13,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "18b38177-33a6-4a4b-86ec-5de8ccd482e5",
      "evidence": "The presentation highlights the benefits of partnering with AbCellera.",
      "position": 1,
      "objective": "The potential consequences of not partnering with AbCellera",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}